Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease

被引:59
作者
Chan, GW
Gorgun, G
Miller, KB
Foss, FM
机构
[1] Tufts Univ, New England Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02111 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
dendritic cells; transplant; graft-versus-host disease (GVHD); chimerism;
D O I
10.1053/bbmt.2003.50006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-host disease (GVHD) causes significant morbidity and mortality in patients undergoing allogeneic bone marrow transplantation following either a conventional or reduced-intensity preparative regimen. In a murine model, inactivation of host dendritic cells (DCs) was associated with a significant reduction in acute GVHD, suggesting that host DCs may play an important role in the pathogenesis of acute GVHD. The role of host DCs in the development of GVHD following allogeneic stem cell transplantation in humans, however, is unclear. We examined DC chimerism in patients with various hematologic malignancies who underwent a reduced-intensity preparative regimen of extracorporeal photophoresis, pentostatin, and reduced-dose total body irradiation (n = 21) or a conventional preparative regimen of cyclophosphamide and total body irradiation (n = 3). Full donor hematopoietic reconstitution was demonstrated in 19 of 21 patients who underwent a reduced-intensity preparative regimen and in all patients who underwent a conventional preparative regimen. Grade 0 to I acute GVHD and limited or no chronic GVHD were observed in 18 patients who underwent a reduced-intensity regimen and 1 patient who underwent a conventional regimen who achieved full donor DC chimerism at day +100 posttransplantation. In contrast, grade H to IV acute GVHD and extensive chronic GVHD were observed in the 2 patients who underwent a conventional regimen and the I patient who underwent a reduced-intensity regimen who had host rather than donor DC chimerism. The persistence of host DCs at day +100 posttransplantation is correlated with the development of severe acute and chronic GVHD (P = .001). Host DCs may represent a therapeutic target for reducing GVHD in allogeneic bone marrow transplants. (C) 2003 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 30 条
  • [1] Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease
    Alcindor, T
    Gorgun, G
    Miller, KB
    Roberts, TF
    Sprague, K
    Schenkein, DP
    Foss, FM
    [J]. BLOOD, 2001, 98 (05) : 1622 - 1625
  • [2] BONE-MARROW TRANSPLANTATION
    ARMITAGE, JO
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (12) : 827 - 838
  • [3] Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients
    Auffermann-Gretzinger, S
    Lossos, IS
    Vayntrub, TA
    Leong, W
    Grumet, FC
    Blume, KG
    Stockerl-Goldstein, KE
    Levy, R
    Shizuru, JA
    [J]. BLOOD, 2002, 99 (04) : 1442 - 1448
  • [4] Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): Report of a workshop of the European Group for Blood and Marrow Transplantation (EBMT)
    Bacigalupo A.
    [J]. Bone Marrow Transplantation, 2000, 25 (8) : 803 - 805
  • [5] High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions
    Badros, A
    Barlogie, B
    Morris, C
    Desikan, R
    Martin, SR
    Munshi, N
    Zangari, M
    Toor, A
    Cottler-Fox, M
    Fassas, A
    Aniassie, E
    Schichman, S
    Tricot, G
    [J]. BLOOD, 2001, 97 (09) : 2574 - 2579
  • [6] Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients
    Basara, N
    Blau, WI
    Römer, E
    Rudolphi, M
    Bischoff, M
    Kirsten, D
    Sanchez, H
    Günzelmann, S
    Fauser, AA
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (01) : 61 - 65
  • [7] Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
    Childs, R
    Clave, E
    Contentin, N
    Jayasekera, D
    Hensel, N
    Leitman, S
    Read, EJ
    Carter, C
    Bahceci, E
    Young, NS
    Barrett, AJ
    [J]. BLOOD, 1999, 94 (09) : 3234 - 3241
  • [8] Clark FJ, 2001, BLOOD, V98, p653A
  • [9] Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity
    Cull, GM
    Haynes, AP
    Byrne, JL
    Carter, GI
    Miflin, G
    Rebello, P
    Hale, G
    Waldmann, H
    Russell, NH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) : 754 - 760
  • [10] Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis
    Cutler, C
    Giri, S
    Jeyapalan, S
    Paniagua, D
    Viswanathan, A
    Antin, JH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3685 - 3691